{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:55:28Z","timestamp":1793156128562,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.clineuro.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T23:15:40Z","timestamp":1537053340000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9470-5890","authenticated-orcid":false,"given":"Victor M.","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Texakalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrie L.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania A.","family":"Mekary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clineuro.2018.09.019_bib0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2018.09.019_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clineuro.2016.01.010","article-title":"Second surgery for recurrent glioblastoma: a concise overview of the current literature","volume":"142","author":"Montemurro","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clineuro.2018.09.019_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.wneu.2018.04.016","article-title":"The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis","volume":"115","author":"Lu","year":"2018","journal-title":"World Neurosurg."},{"issue":"23","key":"10.1016\/j.clineuro.2018.09.019_bib0020","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1200\/JCO.2004.06.181","article-title":"Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)","volume":"22","author":"Brandes","year":"2004","journal-title":"J. Clinical Oncol."},{"issue":"7","key":"10.1016\/j.clineuro.2018.09.019_bib0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/neuonc\/noq030","article-title":"Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004","volume":"12","author":"Bauchet","year":"2010","journal-title":"Neuro Oncol."},{"issue":"7","key":"10.1016\/j.clineuro.2018.09.019_bib0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","article-title":"Antiepileptic drug interactions - principles and clinical implications","volume":"8","author":"Johannessen","year":"2010","journal-title":"Curr. Neuropharmacology."},{"issue":"7","key":"10.1016\/j.clineuro.2018.09.019_bib0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.2042-7158.2011.01282.x","article-title":"No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy","volume":"63","author":"Suzuki","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"10.1016\/j.clineuro.2018.09.019_bib0045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2018.09.019_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Annu. Rev. Biochem"},{"issue":"6","key":"10.1016\/j.clineuro.2018.09.019_bib0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12032-014-0985-5","article-title":"Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience","volume":"31","author":"Bezecny","year":"2014","journal-title":"Med. Oncol. (Northwood, Lond., Engl.)"},{"issue":"9","key":"10.1016\/j.clineuro.2018.09.019_bib0060","doi-asserted-by":"crossref","first-page":"14666","DOI":"10.18632\/oncotarget.14716","article-title":"Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression","volume":"8","author":"Tseng","year":"2017","journal-title":"Oncotarget."},{"issue":"10","key":"10.1016\/j.clineuro.2018.09.019_bib0065","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.seizure.2014.06.015","article-title":"Survival analysis for valproic acid use in adult glioblastoma multiforme: a meta-analysis of individual patient data and a systematic review","volume":"23","author":"Yuan","year":"2014","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11060-016-2191-0","article-title":"Does the choice of antiepileptic drug affect survival in glioblastoma patients?","volume":"129","author":"Knudsen-Baas","year":"2016","journal-title":"J. Neurooncol."},{"issue":"9","key":"10.1016\/j.clineuro.2018.09.019_bib0075","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/13543784.2012.694425","article-title":"Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results","volume":"21","author":"Berendsen","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"7","key":"10.1016\/j.clineuro.2018.09.019_bib0080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold","year":"2016","journal-title":"J. Clin."},{"issue":"7","key":"10.1016\/j.clineuro.2018.09.019_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PloS Med."},{"issue":"7414","key":"10.1016\/j.clineuro.2018.09.019_bib0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ : Br. Med. J."},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clin. Trials"},{"issue":"7109","key":"10.1016\/j.clineuro.2018.09.019_bib0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Res. Ed.)"},{"issue":"4","key":"10.1016\/j.clineuro.2018.09.019_bib0105","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.clineuro.2018.09.019_bib0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"7454","key":"10.1016\/j.clineuro.2018.09.019_bib0115","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ (Clin. Res. Ed.)."},{"key":"10.1016\/j.clineuro.2018.09.019_bib0120","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"Wells","year":"2009"},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","article-title":"Valproic acid use during radiation therapy for glioblastoma associated with improved survival","volume":"86","author":"Barker","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol Phys."},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-016-2054-8","article-title":"Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II\/III gliomas treated with temozolomide","volume":"127","author":"Redjal","year":"2016","journal-title":"J Neurooncol."},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02688697.2011.638996","article-title":"Effect of valproic acid on the outcome of glioblastoma multiforme","volume":"26","author":"Tsai","year":"2012","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.clineuro.2018.09.019_bib0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jns.2018.04.004","article-title":"Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: retrospective multicentre study in 285 Italian patients","volume":"390","author":"Rigamonti","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2018.09.019_bib0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3171\/2012.10.JNS12169","article-title":"Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme","volume":"118","author":"Guthrie","year":"2013","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.clineuro.2018.09.019_bib0150","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/neuonc\/nov238","article-title":"Prognostic relevance of epilepsy at presentation in glioblastoma patients","volume":"18","author":"Berendsen","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.clineuro.2018.09.019_bib0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clineuro.2017.11.015","article-title":"Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: a systematic review and meta-analysis","volume":"164","author":"Lu","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"10.1016\/j.clineuro.2018.09.019_bib0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/neuros\/nyx084","article-title":"Improved survival with decreased wait time to surgery in glioblastoma patients presenting with seizure","volume":"81","author":"Flanigan","year":"2017","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archneurol.2010.2","article-title":"Morphological characteristics of brain tumors causing seizures","volume":"67","author":"Lee","year":"2010","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2018.09.019_bib0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3171\/2008.4.17536","article-title":"Independent association of extent of resection with survival in patients with malignant brain astrocytoma","volume":"110","author":"McGirt","year":"2009","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.clineuro.2018.09.019_bib0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/02688697.2014.967750","article-title":"Improvement in treatment results of glioblastoma over the last three decades and beneficial factors","volume":"29","author":"Kawano","year":"2015","journal-title":"Br. J. Neurosurg."},{"issue":"12","key":"10.1016\/j.clineuro.2018.09.019_bib0180","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/neuonc\/not122","article-title":"Time trends in glioblastoma multiforme survival: the role of temozolomide","volume":"15","author":"Dubrow","year":"2013","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.clineuro.2018.09.019_bib0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-018-2897-2","article-title":"Older studies can underestimate prognosis of glioblastoma biomarker in meta-analyses: a meta-epidemiological study for study-level effect in the current literature","volume":"139","author":"Lu","year":"2018","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3171\/jns.2003.99.3.0467","article-title":"Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project","volume":"99","author":"Laws","year":"2003","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.clineuro.2018.09.019_bib0200","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0165-3806(96)00141-1","article-title":"Age-dependent effects of glutamate toxicity in the hippocampus","volume":"97","author":"Liu","year":"1996","journal-title":"Brain Res. Dev. Brain Res."},{"issue":"17","key":"10.1016\/j.clineuro.2018.09.019_bib0205","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/cncr.29439","article-title":"Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clineuro.2018.09.019_bib0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","article-title":"P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy","volume":"72","author":"Oberndorfer","year":"2005","journal-title":"J. Neurooncol."},{"issue":"11","key":"10.1016\/j.clineuro.2018.09.019_bib0215","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/aje\/kwg062","article-title":"Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it","volume":"157","author":"Weiss","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.clineuro.2018.09.019_bib0220","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/neuonc\/not095","article-title":"Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma?","volume":"15","author":"Weller","year":"2013","journal-title":"Neuro Oncol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718303810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718303810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:29:09Z","timestamp":1759588149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846718303810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":44,"alternative-id":["S0303846718303810"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.09.019","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}